The use of hypertonic solutions in sepsis

Trends in Anaesthesia and Critical Care

Volumn 3, Issue 1, 2013, Pages 37-41

  Van Haren, Frank M P ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

Cardiac output; Fluid resuscitation; Hypertonic; Outcome; Sepsis

Indexed keywords

ACTIVATED PROTEIN C; BICARBONATE; HYPERTONIC SOLUTION; MITOGEN ACTIVATED PROTEIN KINASE P38; SODIUM CHLORIDE; STARCH;

ADVERSE OUTCOME; BLOOD CLOTTING DISORDER; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DEHYDRATION; FLUID THERAPY; GENE EXPRESSION; HEART CONTRACTION; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPERNATREMIA; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; KIDNEY FAILURE; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL; TREATMENT OUTCOME;

EID: 84873101221     PISSN: 22108440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tacc.2012.10.001     Document Type: Review

References (45)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Burchardi H., Schneider H. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy. Pharmacoeconomics 2004, 22:793-813.
3. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
4. Boyd J.H., Forbes J., Nakada T.A., Walley K.R., Russell J.A. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011, 39:259-265.
5. Murphy C.V., Schramm G.E., Doherty J.A., Reichley R.M., Gajic O., Afessa B., et al. The importance of fluid management in acute lung injury secondary to septic shock. Chest 2009, 136:102-109.
6. van Haren F. Hypertonic fluids: clinical use. Netherlands Journal of Critical Care Medicine 2001, 5. XV-IX.
7. Krausz M.M., Semenikhina L., Hirsh M. Lactated Ringer's solution and hypertonic saline improve survival in uncontrolled hemorrhagic shock in female rats in metestrus. J Surg Res 2006, 132:23-31.
8. Mauritz W., Schimetta W., Oberreither S., Polz W. Are hypertonic hyperoncotic solutions safe for prehospital small-volume resuscitation? Results of a prospective observational study. Eur J Emerg Med 2002, 9:315-319.
9. Moon P.F., Hollyfield-Gilbert M.A., Myers T.L., Uchida T., Kramer G.C. Fluid compartments in hemorrhaged rats after hyperosmotic crystalloid and hyperoncotic colloid resuscitation. Am J Physiol 1996, 270:F1-F8.
10. Vassar M.J., Fischer R.P., O'Brien P.E., Bachulis B.L., Chambers J.A., Hoyt D.B., et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg 1993, 128:1003-1011. discussion 1011-1003.
11. Jarvela K., Koskinen M., Koobi T. Effects of hypertonic saline (7.5%) on extracellular fluid volumes in healthy volunteers. Anaesthesia 2003, 58:878-881.
12. Smith G.J., Kramer G.C., Perron P., Nakayama S., Gunther R.A., Holcroft J.W. A comparison of several hypertonic solutions for resuscitation of bled sheep. J Surg Res 1985, 39:517-528.
13. Giusti-Paiva A., Martinez M.R., Bispo-da-Silva L.B., Salgado M.C., Elias L.L., Antunes-Rodrigues J. Vasopressin mediates the pressor effect of hypertonic saline solution in endotoxic shock. Shock 2007, 27:416-421.
14. Ing R.D., Nazeeri M.N., Zeldes S., Dulchavsky S.A., Diebel L.N. Hypertonic saline/dextran improves septic myocardial performance. Am Surg 1994, 60:505-507. discussion 508.
15. Mouren S., Delayance S., Mion G., Souktani R., Fellahi J.L., Arthaud M., et al. Mechanisms of increased myocardial contractility with hypertonic saline solutions in isolated blood-perfused rabbit hearts. Anesth Analg 1995, 81:777-782.
16. Ben-Haim S.A., Edoute Y., Hayam G., Better O.S. Sodium modulates inotropic response to hyperosmolarity in isolated working rat heart. Am J Physiol 1992, 263:H1154-H1160.
17. Schroth M., Plank C., Meissner U., Eberle K.P., Weyand M., Cesnjevar R., et al. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Pediatrics 2006, 118:e76-e84.
18. McAlister V., Burns K.E., Znajda T., Church B. Hypertonic saline for peri-operative fluid management. Cochrane Database Syst Rev 2010, CD005576.
19. Poli-de-Figueiredo L.F., Cruz R.J., Sannomiya P., Rocha E.S.M. Mechanisms of action of hypertonic saline resuscitation in severe sepsis and septic shock. Endocr Metab Immune Disord Drug Targets 2006, 6:201-206.
20. Kolsen-Petersen J.A. Immune effect of hypertonic saline: fact or fiction?. Acta Anaesthesiol Scand 2004, 48:667-678.
21. Angle N., Cabello-Passini R., Hoyt D.B., Loomis W.H., Shreve A., Namiki S., et al. Hypertonic saline infusion: can it regulate human neutrophil function?. Shock 2000, 14:503-508.
22. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994, 265:808-811.
23. Ciesla D.J., Moore E.E., Gonzalez R.J., Biffl W.L., Silliman C.C. Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. Shock 2000, 14:265-269. discussion 269-270.
24. Shukla A., Hashiguchi N., Chen Y., Coimbra R., Hoyt D.B., Junger W.G. Osmotic regulation of cell function and possible clinical applications. Shock 2004, 21:391-400.
25. van Haren F.M., Sleigh J., Cursons R., La Pine M., Pickkers P., van der Hoeven J.G. The effects of hypertonic fluid administration on the gene expression of inflammatory mediators in circulating leucocytes in patients with septic shock: a preliminary study. Ann Intensive Care 2011, 1:44.
26. Dellinger R.P. Inflammation and coagulation: implications for the septic patient. Clin Infect Dis 2003, 36:1259-1265.
27. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
28. Ranieri V.M., Thompson B.T., Barie P.S., Dhainaut J.F., Douglas I.S., Finfer S., et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012, 366:2055-2064.
29. Proctor K.G. Hypertonic resuscitation: is it all in the timing?. Crit Care Med 2008, 36:2692-2693.
30. Steltzer H., Owen A.N., Krafft P., Weinstabl C., Hammerle A.F. Haemodynamic evaluation during small volume resuscitation in patients with acute respiratory failure. Eur J Emerg Med 1994, 1:19-26.
31. Hannemann L., Reinhart K., Korell R., Spies C., Bredle D.L. Hypertonic saline in stabilized hyperdynamic sepsis. Shock 1996, 5:130-134.
32. Muller L., Lefrant J.Y., Jaber S., Louart G., Mahamat A., Ripart J., et al. [Short term effects of hypertonic saline during severe sepsis and septic shock]. Ann Fr Anesth Reanim 2004, 23:575-580.
33. Oliveira R.P., Weingartner R., Ribas E.O., Moraes R.S., Friedman G. Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Med 2002, 28:1574-1581.
34. Fang Z.X., Li Y.F., Zhou X.Q., Zhang Z., Zhang J.S., Xia H.M., et al. Effects of resuscitation with crystalloid fluids on cardiac function in patients with severe sepsis. BMC Infect Dis 2008, 8:50.
35. Zhu G.C., Quan Z.Y., Shao Y.S., Zhao J.G., Zhang Y.T. [The study of hypertonic saline and hydroxyethyl starch treating severe sepsis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2011, 23:150-153.
36. Chopra A., Kumar V., Dutta A. Hypertonic versus normal saline as initial fluid bolus in pediatric septic shock. Indian J Pediatr 2011, 78:833-837.
37. Dubick M.A., Wade C.E. A review of the efficacy and safety of 7.5% NaCl/6% dextran 70 in experimental animals and in humans. J Trauma 1994, 36:323-330.
38. Dubick M.A., Bruttig S.P., Wade C.E. Issues of concern regarding the use of hypertonic/hyperoncotic fluid resuscitation of hemorrhagic hypotension. Shock 2006, 25:321-328.
39. Mazzoni M.C., Borgstrom P., Intaglietta M., Arfors K.E. Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion. Circ Shock 1990, 31:407-418.
40. Kolsen-Petersen J.A., Nielsen J.O., Tonnesen E. Acid base and electrolyte changes after hypertonic saline (7.5%) infusion: a randomized controlled clinical trial. Scand J Clin Lab Invest 2005, 65:13-22.
41. van Haren F.M., Sleigh J., Boerma E.C., La Pine M., Bahr M., Pickkers P., et al. Hypertonic fluid administration in patients with septic shock: a prospective randomized controlled pilot study. Shock 2012, 37:268-275.
42. Kamel H., Navi B.B., Nakagawa K., Hemphill J.C., Ko N.U. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 2011, 39:554-559.
43. Mortazavi M.M., Romeo A.K., Deep A., Griessenauer C.J., Shoja M.M., Tubbs R.S., et al. Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis. J Neurosurg 2012, 116:210-221.
44. Sakr Y., Payen D., Reinhart K., Sipmann F.S., Zavala E., Bewley J., et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007, 98:216-224.
45. Myburgh J., Li Q., Heritier S., Dan A., Glass P. Statistical analysis plan for the Crystalloid Versus Hydroxyethyl Starch Trial (CHEST). Crit Care Resusc 2012, 14:44-52.